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ABSTRACT
Traumatic brain injury (TBI) and subsequent rises in intracranial pressure (ICP)
are associated with high mortality and has a number of physical and behavorial
consequences to which the specific causes are unknown. We hypothesized that exposure
of neuronal cells to elevated pressure can cause neurite retraction and / or apoptosis. Loss
of communication between neurons due to these cellular-level events may play a part in
complications seen in TBI patients, such as neurodegenerative diseases, increased
anxiety, fear, depression, cognitive problems, as well as motor and visual deficits. In the
present study, the effect of elevated hydrostatic pressure was evaluated at the cellular
level in vitro by examining cell morphology, particularly neurite retraction and extension,
as well as apoptosis. Neuro-2A cells (a mouse neuroblastoma cell line) were plated in cell
culture dishes, as well as on soft polyacrylamide gel + type I collagen substrates. The
cells were imaged using phase contrast microscopy (Nikon) before and after exposure to
25 or 35 mmHg of hydrostatic pressure in a custom-made pressure chamber for 15, 30,
60 min, as well as 4 and 6 hours. Pressure values were chosen to model elevated ICP
correlated with moderate to severe TBI. Using the Fiji software, the post-pressure images
were compared with the pre-pressure images of the same cells and the data were reported
as normalized change in neurite length per cell. Additionally, TUNEL assay was
performed using a commercially available kit (TiterTACSTM, Trevigen) to quantify
apoptotic cells after exposure of Neuro-2A cells to 35 mmHg pressure. Results indicate
that neurite length decreased significantly (p<0.05) when Neuro-2A cells were exposed to
a pressure of 35 mmHg. When results are compared from 15, 30, 60 minutes and 4 hours

ii

of pressure exposure, it appears that neurite retraction is correlated with exposure time.
To further understand these morphological changes, the Rho/ROCK pathway was
examined as a potential pathway involved in the mechanotransduction of hydrostatic
pressure by neuronal cells. By using Y-27632 as a p160ROCK inhibitor, it was
demonstrated that the pressure-induced neurite retraction response was blocked, therefore
indicating the pathway’s involvement. The results of TUNEL assay indicated that the
number of apoptotic cells were similar between the no pressure control and the cells
exposed to 35 mmHg of pressure for 24 hours. The results of the present study provide
evidence that elevated hydrostatic pressure causes Neuro-2A cell neurite retraction in a
time-dependent manner in vitro. The model highlights the importance of urgent ICP
clinical management, as elevated ICP caused by TBI may have a negative impact on
neuronal tissue and contribute to further consequences.

iii

DEDICATION
I would like to dedicate this thesis to my family and friends. I am forever grateful
to my parents for raising me with love and instilling in me the values for success, as well
as for providing me with the wonderful opportunity to grow up as a Third Culture Kid.
Words cannot explain how that international experience has molded my character and
outlook on life. Thank you for fostering my passion for creativity and curiosity for
knowledge, for loving me, guiding me, supporting me, and believing in me. To my
wonderful friends, thank you for your endless love, kindness, and encouragement. You
made the rough times bearable and the great times the best. Without your support this
work would have not been possible.

iv

ACKNOWLEDGMENTS
I would like to thank my advisor Dr. Jiro Nagatomi for his influence on both my
undergraduate and graduate career. I am grateful for the continued patience, guidance,
and support he has shown me. Without his help, none of this would have been possible.
Thank you to the past and present members of the Cell Mechanics and
Mechanobiology Laboratory. Without the strong examples set by older members and the
assistance of current members, I would not have been able to complete this work.
I would like to acknowledge my committee members Dr. Dan Simionescu and Dr.
Delphine Dean for their knowledgeable input and advice.
Thank you to Clemson University for not only the opportunity to pursue research
in the Department of Bioengineering, but also for an incredible undergraduate
experience.

v

TABLE OF CONTENTS
Page
TITLE PAGE .................................................................................................................. i
ABSTRACT .................................................................................................................... ii
DEDICATION .............................................................................................................. iv
ACKNOWLEDGMENTS ............................................................................................. v
LIST OF FIGURES ...................................................................................................... ix
CHAPTER
1.

INTRODUCTION AND BACKGROUND ............................................... 1
1.1 Introduction ...................................................................................... 1
1.2 Anatomy and Physiology of the Brain ........................................... 2
1.2.1 Structures ............................................................................... 2
1.2.2 Cell Types .............................................................................. 2
1.2.3 Vasculature and Intracranial Pressure .................................... 3
1.3 Traumatic Brain Injury .................................................................. 4
1.3.1 Types of Traumatic Brain Injury ........................................... 4
1.3.2 Symptoms and Consequences of TBI .................................... 5
1.3.2.1 Short-term Consequences ................................................... 5
1.3.2.2 Long-term Consequences.................................................... 7
1.3.2.2.1 Neurodegenerative Diseases ............................................ 8
1.3.2.2.2 Glial Scar Formation ........................................................ 9
1.3.2.2.3 Elevated Intracranial Pressure........................................ 10
1.3.2 Current Treatment for Controlling ICP................................ 11
1.3.2.1 Medical Interventions ....................................................... 13
1.3.2.2 Surgical Interventions ....................................................... 15
1.4 Neuronal Cell Responses to Stress................................................ 16
1.2.1 Neurite Retraction ................................................................ 16
1.2.1.1 Causes and Mechanisms ................................................... 16
1.2.1.2 Indications and Consequences .......................................... 17
1.2.2 Neurite Retraction in TBI .................................................... 18
1.2.2.1 In Vitro Findings ............................................................... 19
1.2.2.2 In Vivo Findings ................................................................ 20
1.5 Effects of Hydrostatic Pressure on Neuronal Cells ..................... 21
1.5.1 Associated Pathologies ........................................................ 21
1.5.2 Effect on Cells...................................................................... 22

vi

TABLE OF CONTENTS (CONTINUED)
Page
1.5.2.1 Retinal Ganglion Cells ..................................................... 22
1.5.2.2 PC12 Cells ........................................................................ 24
2.

RESEARCH RATIONALE ...................................................................... 26
2.1 Rationale ......................................................................................... 26
2.2 Hypotheses ...................................................................................... 26

3.

MATERIALS AND METHODS .............................................................. 29
3.1 Pressure System ............................................................................. 29
3.2 Cell Culture .................................................................................... 31
3.3 Soft Substrate Coating................................................................... 31
3.3.1 Coverslip Acid Washing ...................................................... 31
3.3.2 Coverslip Activation ............................................................ 32
3.3.3 Polyacrylamide Gel Coating ................................................ 32
3.3.4 Collagen Type I Coating ...................................................... 33
3.3.5 Coomassie Blue Staining ..................................................... 34
3.3.6 Cell Seeding onto Gel Coverslips ........................................ 34
3.4 Pressure Experiments .................................................................... 34
3.5 Microscopy...................................................................................... 36
3.6 Neurite Length Analysis ................................................................ 36
3.6.1 Image Analysis..................................................................... 36
3.6.2 Calculations.......................................................................... 36
3.7 p160ROCK Inhibition ................................................................... 37
3.7.1 Part One: Pressure and Y-27632 .......................................... 37
3.7.2 Part Two: LPA and Y-27632 ............................................... 37
3.8 TUNEL Assay ................................................................................. 38
3.9 Polyacrylamide / Collagen Type I Coating of Substrates........... 38
3.10 Statistical Analysis ....................................................................... 38

4.

RESULTS ................................................................................................... 39
4.1 Neuro2A Cell Neurite Extension .................................................. 39
4.2 Neurite Response to Pressure Exposure ...................................... 40
4.2.1 Hard Substrate .................................................................... 40
4.2.2 Soft Substrate ..................................................................... 42
4.3 p160 ROCK Inhibition .................................................................. 45
4.4 Apoptosis Study.............................................................................. 47

5.

DISCUSSION ............................................................................................. 49
5.1 Neuro2A Cell Differentiation ........................................................ 49

vii

TABLE OF CONTENTS (CONTINUED)
Page
5.2 Neurite Response to Pressure Exposure ...................................... 50
4.2.1 Hard Substrate .................................................................... 50
4.2.2 Soft Substrate ..................................................................... 52
5.3 p160 ROCK Inhibition .................................................................. 54
5.4 Apoptosis Study.............................................................................. 54
5.5 Limitations ...................................................................................... 55
6.

CONCLUSIONS AND RECOMMENDATIONS................................... 57

REFERENCES............................................................................................................. 61

viii

LIST OF FIGURES
Figure

Page

Figure 1: Pressure Chamber 1 ..................................................................................... 30
Figure 2: Pressure Chamber 2 ..................................................................................... 30
Figure 3: Cell Culture Dish Grid Schematic ............................................................... 35
Figure 4: Phase Contrast Images of Neuro2A Cells in Growth Medium and
Serum-Free Medium ................................................................................... 39
Figure 5: Phase Contrast Images of Neuro2A Cells Before and After Pressure
Application................................................................................................... 40
Figure 6: Average Normalized Change in Neurite Length Over 1 Hour .................... 41
Figure 7: Average Normalized Change in Neurite Length Over Time at
35 mmHg Pressure ....................................................................................... 42
Figure 8: Coomassie Blue Staining of Polyacrylamide Gel Coverslips ...................... 43
Figure 9: Phase Contrast Images of Neuro2A Cells Seeded on Soft Substrate........... 44
Figure 10: Average Normalized Change in Neurite Length Over 1 Hour on
Hard and Soft Substrates............................................................................. 45
Figure 11: Average Normalized Change in Neurite Length Over 1 Hour for
Treatment Groups With or Without Exposure to Inhibitor Y-27632. ......... 46
Figure 12: Quantification of Apoptosis in Neuro2A Cells Using HT TiterTACS
Assay ........................................................................................................... 48

ix

CHAPTER ONE
INTRODUCTION AND BACKGROUND
1.1 Introduction
Traumatic brain injury is an immediate insult to the brain due to an external
mechanical force that can range from mild to severe, resulting in both immediate and
long-term effects (Caeyenberghs et al, 2014). Approximately 1.7 million traumatic brain
injuries (TBI), 52,000 of which are fatal, occur every year in the United States, with an
associated annual treatment cost of $70 billion (MedGadget, 2016). TBIs can result from
a number of events including falls, vehicle accidents, assault, sports impacts, and
battlefield blasts, and account for 50% of injuries sustained in war zone conflicts
(MedGadget, 2016). The severity of TBI is classified as either mild, moderate, or severe.
Concussions are a common type of mild TBI that occur largely due to sports impact
injuries, and often go unreported or untreated due to their lack in severity. Moderate and
severe TBIs are associated with higher mortality rates, and often result in severe
disabilities (Caeyenberghs et al, 2014). Treatments exist to treat some secondary injury
mechanisms, such as corticosteroids or calcium channel blockers (Xiong et al, 2009).
However, no reliable treatment currently exists to alleviate the effects of TBI as a whole
and prevent future consequences.
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1.2 Anatomy and Physiology of the Brain
1.2.1 Structures
The brain is the main organ of the nervous system and acts a control center that
receives and processes information, then dictates responses. It is a complex structure with
several tissue and cell types (McKinley et al, 2012).
The cerebral cortex, the outermost layer of the brain, is composed of gray matter,
which contains motor neurons and interneuron cell bodies, dendrites, and unmyelinated
axons (McKinley et al, 2012).
Cerebrospinal fluid (CSF) is an important component of the central nervous system
(CNS) that circulates in the ventricles and subarachnoid space, and surrounds all exposed
surfaces of the brain and spinal cord. The clear liquid not only protects and supports the
brain, but also facilitates the transportation of nutrients, waste, and gases such as carbon
dioxide and oxygen. The choroid plexus, a layer of ependymal cells and capillaries that is
housed in each ventricle, produces CSF. After circulating in the ventricles, CSF enters the
subarachnoid space where it removes waste products, and is then absorbed via arachnoid
villi into the venous blood stream for eventual urinary excretion (McKinley et al, 2012).
1.2.2 Cell Types
Brain tissue is composed of several cell types including neurons, astrocytes,
microglial cells, oligodendrocytes, and ependymal cells (Pekna et al, 2012). Interneurons
are the primary cell type of the central nervous system (CNS) and are responsible for
signal transmission between sensory and motor neurons. These specific neurons are
multipolar, meaning that they have multiple neurites- namely one axon and several
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dendrites. Dendrites receive sensory information from stimuli and send it to the cell body
for processing, from which an output signal is transported via the axon to the effector
cell. This allows the interneurons to receive, store, and interpret sensory information, then
dictate the response. Depending on the complexity of the response, several interneurons
may be involved in the transmission process (McKinley et al, 2012). Thus, properly
structured interneuron networks are essential to facilitate full functional signal processing
and communication.
Astrocytes, microglial cells, oligodendrocytes and ependymal cells are classified as
glial cells, which support the function of neurons and are able to undergo mitosis.
Astrocytes are the most common type of glial cell. Their star-shaped structure allows
them to provide structural support to neurons and organize nervous tissue, as well as
contribute to forming the blood-brain barrier (BBB) through their connection with
capillaries in the brain. Additionally, astrocytes regulate fluid composition in the brain by
controlling molecular diffusion between blood and interstitial fluid. More importantly,
astrocytes assist in neuronal development and synapse formation through the release of
molecular signals. Ependymal cells are responsible for producing cerebral spinal fluid
(CSF) in a structure called the choroid plexus. Microglial cells act as macrophages of the
nervous system by migrating through the tissue and phagocytizing debris.
Oligodendrocytes wrap around the axons of neurons to form the myelin sheath, which
protects the axon while hastening signal transmission (McKinley et al, 2012).
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1.2.3 Vasculature and Intracranial Pressure
Intracranial pressure (ICP) is determined by three components including tissue
(brain and spinal cord), blood, and cerebrospinal fluid (CSF), which are housed in the
skull and intervertebral canal, creating a fixed incompressible system. The Monroe-Kellie
hypothesis states that the total intracranial volume remains constant. Therefore, when a
volume increase in one of these components occurs, an equal decrease in another
accommodates the change to maintain the appropriate intracranial pressure. For a normal
healthy adult, the ICP ranges between 5 and 15 mmHg (Rangel-Castillo et al, 2008).
Another factor essential to maintain optimal ICP is the cerebral perfusion pressure
(CPP). The CPP controls the cerebral blood flow (CBF) via the paired carotid and
vertebral arteries, ensuring adequate blood flow and delivery of oxygen and glucose to
brain tissue. More specifically, the blood vessels detect carbon dioxide concentration in
the blood (partial pressure), and respond to increased partial pressure by vasodilation in
order to increase CBF, and respond to decreased partial pressure by vasoconstriction,
resulting in lowered CBF (Snyder, 2012). The CPP also depends on the mean arterial
pressure (MAP), which is determined based on the individual’s systolic and diastolic
blood pressure. In order to maintain adequate CPP, the ICP must be reduced, or the MAP
increased (Rangel-Castillo et al, 2008).
1.3 Traumatic Brain Injury
1.3.1 Types of Traumatic Brain Injury
Depending on the type and location of the injury, certain structures within the brain
are affected. Two main types of TBI occur including 1) focal trauma and 2) diffuse
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axonal injury (DAI) (Gaetz, 2004). Focal trauma constitutes direct mechanical damage to
brain tissue which affects local neurons and cerebrovasculature and leads to ischemia and
cytotoxic cascades. It can also result in traumatically induced masses such as hematomas
and hemorrhagic contusions. DAI accounts for about 40-50% of dysfunction associated
with TBI. It affects superficial layers of brain tissue, particularly neurons and their axons,
through acceleration and deceleration forces, then radiates deeper through the white
matter (Gaetz, 2004). Specifically, DAI tends to affect certain brain regions including the
parasagittal white matter of the cerebral cortex, the corpus callosum, and the pontinemesencephalic junction adjacent to the superior cerebellar peduncles (Ashley, 2010).
1.3.2 Symptoms and Consequences of TBI
In moderate to severe TBI, there is a primary injury due to the initial impact which
typically results in either a) contusions, lacerations, and intracranial hemorrhage, or b)
diffuse axonal injury (Werner et al, 2007). Secondary injury results downstream of the
primary insult as a consequence of cascading pathological biochemical processes such as
disruption of cellular calcium homeostasis, increased free radical presence, lipid
peroxidation, inflammation, apoptosis, and mitochondrial dysfunction (Xiong et al,
2009). Several secondary events may occur, including elevated intracranial pressure
(ICP) or intracranial hypertension, and cerebral ischemia (Werner et al, 2007).
1.3.2.1 Short-Term Consequences
Upon impact, direct cell damage and death may occur immediately. Neuronal and
glial cell death lead to disruption in neuronal circuitry due to synapse and neurite
destruction between cells. Additionally, TBI disrupts blood flow and the blood-brain
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barrier, CSF production and regulation, as well as cell metabolism and function (Pekna et
al, 2012). Traumatic hemorrhagic contusions, as well as epidural hematomas or subdural
hematomas may occur upon injury (Rangel-Castillo et al, 2008) and contribute to blood
volume increase inside the skull (Alali et al, 2013). Cerebral edema, an increase in brainwater content either intracellularly or extracellularly, may occur and increase fluid
volume inside the skull (Alali et al, 2013).
Additionally, patients who suffer non-fatal severe TBI may experience coma or
amnesia (Centers for Disease Control and Prevention, 2017). Other potential effects of
severe TBI that may be either short or long-term include deficits in cognitive functions
(attention and memory), motor functions (weakness, impaired balance and coordination),
sensation (hearing, vision, touch), and emotion (depression, anxiety, aggression,
impulsivity, personality changes) (Centers for Disease Control and Prevention, 2017).
In DAI, when the initial damage occurs, the local neurons experience cell
membrane disruption, which leads to cytotoxic biochemical cascades and decline in cell
health and function. More specifically, small ion species are believed to enter the
disrupted axons, and inflict damage on the microtubules that compose the cytoskeleton
(Gaetz, 2004). These local events eventually extend and affect distant structures as well
(Ashley, 2010).
On the cellular level, DAI induces axolemmal permeability, allowing an influx of
Ca2+ in the affected neurons at the primary injury site via calpain activation. This causes
proteolytic digestion of a spectrin, which is a key component of the cytoskeleton
membrane. These neurofilamentary changes may result in axonal cytoskeleton
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mechanical failure. Negative downstream effects may occur such as mitochondrial
migration from the cell body to the axon or axon terminals. Further axonal degeneration
occurs over time. This specific degeneration may occur within days or months and
progresses from initial axonal swelling to axonal bulb swelling, which then results in the
aggregation of microglia. Within the first two years after DAI is sustained, the myelin
sheath ultimately degenerates (Ashley, 2010).
On a macroscopic scale, DAI damages white matter and disrupts tissue organization
in the brain. Previous studies that examined specific brain regions including the superior
longitudinal fasciculus, corpus callosum, and cingulum fibre bundles demonstrated that
TBI associated cognitive impairment correlates with white matter damage (Caeyenberghs
et al, 2014). A study performed by Caeyenberghs et al, examined the effect of DAI on
neural communication networks and found that TBI patients had disrupted topological
organization of white matter networks which could have been responsible for observed
decreased task-switching ability when compared with the control (Caeyenberghs et al,
2014).
1.3.2.2 Long-Term Consequences
Several long-term consequences are observed in TBI patients including those of an
emotional, cognitive, and physical nature. Neuropsychological deficits associated with
cognition include decreased mental flexibility, lack of planning and organizational skills,
poor judgment, impaired attention, trouble with sequencing, speech impairment,
increased impulsive behavior, and deficits with working memory. These effects are
attributed mainly to diffuse axonal injury (DAI, Caeyenberghs et al, 2014). Impaired
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memory has been observed in severe TBI patients, however there have been mixed
reports in terms of mild and moderate TBI cases. Case study results find that sports
impact injury patients sustained memory impairment, whereas veterans who experienced
mild battlefield blast TBIs did not. Additionally, a decreased ability to recollect
autobiographical details in TBI patients was correlated with increased CSF volumes in
the bilateral genual cingulate gyrus, medial temporal lobe, anterior basal ganglia, left
posterior cingulate gyrus, right anterior cingulate gyrus, and right posterior temporal,
superior parietal, inferior parietal, and middle cingulate regions (Esopenko et al, 2017).
1.3.2.2.1 Neurodegenerative Diseases
Previous studies indicate that moderate to severe TBI serve as a significant risk
factor for the eventual development of neurodegenerative diseases such as Parkinson’s
disease (Jafari et al, 2013), Alzheimer’s disease (Mortimer et al, 1991; Fleminger et al,
2003) and amyotrophic lateral sclerosis (ALS, Chen et al, 2007), as well as
frontotemporal dementia (Rosso et al, 2003; Kalkonde et al, 2012). While a holistic
understanding of the all mechanisms responsible for linking the two pathologies remains
unclear, several involved components have been elucidated.
Several correlations between traumatic brain injury and neurodegeneration
associated with Parkinson’s disease (PD) exist. Animal studies have shown that after
brain injury, protein accumulation and aggregation have occurred (Smith et al, 1999;
Iwata et al, 2002), as well as proteosomal dysfunction (Yao et al, 2008), and an increase
in nitrated α-synuclein (Uryu et al, 2003), as seen in PD patients. In post-mortem human
studies, TBI patients exhibited increased levels of α-synuclein. α–synuclein aggregation
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is a key indicator for the development of a neurodegenerative disease, as it is the main
component present in Lewy bodies- abnormal protein aggregates observed in the neurons
of PD dementia patients. It is hypothesized that α-synuclein aggregation may be due to
disruption of axonal transport processes or axonal shear stress (Uryu et al, 2003; Siebert
et al, 2010; Newell et al, 1999; Gaetz, 2004). Additionally, a study by Goldman et al
found that patients with head injuries have overexpression of the alpha-synuclein
(SNCA) gene and elevated levels of Rep1, which increases its transcription, suggesting
that this is a contributor to the α -synuclein aggregation observed in PD (Goldman et al,
2012). Moreover, α -synuclein aggregation activates microglia, which in turn activates α synuclein to aggregate when activated, creating a cycle of α –synuclein upregulation
(Wilms et al, 2009; Zhang et al, 2005).
1.3.2.2.2. Glial Scar Formation
Glial cells become activated as a protective response after neurotrauma in a process
termed “reactive gliosis”. This process encompasses several events including the
hypertrophy of astrocyte extensions, astrocyte proliferation, and elevated amounts of
intermediate filaments. When activated, astrocytes immediately perform beneficial
functions to protect surrounding tissue by preserving neuronal synapses, restricting the
spread of injury, and aiding in wound repair. However, at a later stage of injury, glial scar
activation has been shown to correlate with reduced regeneration of neuronal synapses
and axons (Pekna et al, 2012).
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1.3.2.2.3 Elevated Intracranial Pressure
Several factors compound to result in an increase in intracranial pressure (ICP)
following TBI. As mentioned previously, hemorrhages and hematomas raise blood
volume and edema increases fluid volume. Disruptions in CSF absorption can contribute
to increased CSF volume throughout the CSF cavities, since the excess liquid cannot be
removed and fresh CSF continues to be produced. Foreign bodies acquired during injury,
or depressed skull fractures may also be introduced to the space (Rangel-Castillo et al,
2008). With any or all of these increases in volume in the fixed space within the skull,
intracranial pressure is forced to rise. Additionally, edema can compress cerebral
vasculature, which reduces CBF, increases carbon dioxide concentration and
consequently causes vasodilation and further increases ICP. When ICP increases enough,
the brain loses the ability to autoregulate CBF (Snyder, 2012). ICP associated with mild
to moderate TBI ranges from 20 to 30 mmHg, while an ICP of 40 mmHg or greater is
correlated with severe TBI (Rangel-Castillo et al, 2008).
Rising ICP is often reflected in a patient’s mental status. Early on, the patient may
exhibit confusion, later developing into a state of irritability, and ultimately transcending
into combativeness. Severe headache and vomiting are indicative of subarachnoid
hemorrhage and meningeal irritation as well as tissue compression. Unresponsiveness is a
sign of the later stages of increased ICP. Additional late symptoms include seizures, a
blown pupil, and Cushing reflex as a result of direct compression of the brain cortex
tissue from hematomas or other expanding masses or free blood (Snyder, 2012).
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Increased ICP is known to be responsible for ischemia- when blood flow is
restricted to brain tissue, resulting in cell damage and death, as well as cerebral
herniation. Since the pressure increases in the fixed volume of the skull, sometimes the
brain itself is pressed unnaturally against structures such as the tentorium cerebelli or the
the cranial foramen, through which it herniates (Snyder, 2012). Other types of herniation
that may occur due to elevated ICP include cingulate herniation, which occurs when the
middle lobe of the brain shifts under the falx cerebelli, uncal herniation, which occurs
when the uncus is pressed against the tentorium cerebelli and brain tissue is forced
through the tentorial hiatus, cerebellotonsillar herniation, in which the cerebellum
herniates through the foramen magnum and compresses the brain stem, and finally
transcalvarial herniation, in which brain tissue is displaced to the exterior of the skull if a
skull fracture exists (Snyder, 2012).
1.3.2 Current Treatment for Controlling ICP
The initial stage of severe TBI treatment traditionally take place at the location
where the injury occurred, followed by at the emergency department of the hospital to
which the patient is transported, and ultimately the intensive care unit (ICU). The early
acute care provided is crucial as it could prevent additional consequences and improve
patient outcome. Critical steps include stabilization of the patient, prevention of ICP
increase, and optimization of cerebral perfusion and oxygenation. To do so, medical
personnel monitor the patient using electrocardiography, pulse oxymetry to measure
arterial oxygen saturation, arterial blood pressure, electrolytes, osmolality, central venous
pressure, and systemic temperature (Haddad et al, 2012).
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Since the primary brain injury cannot be repaired in TBI patients, physicians focus
on treating the secondary injuries in hopes of eliminating or reducing further damage that
may lead to long and short-term functional deficits or death. To date, no therapeutic has
been successful in clinical trials to treat TBI secondary injury (Xiong et al, 2009).
Death and disability after severe TBI are most strongly correlated to high ICP,
rather than any other TBI symptom (Xiong et al, 2009). Of those who die within the first
48 hours following injury, the most likely cause is an uncontrolled rise in ICP (Alali et al,
2013). Therefore, it seems vital that ICP is monitored closely when TBI patients receive
treatment for their injuries (Xiong et al, 2009). However, some physicians argue the
benefit from ICP monitoring due to its invasive nature, which could potentially further
harm the patient. For example, results from a survey on practicing neurosurgeons in
Canada, only 20% reported that they were highly confident in the benefit of invasive ICP
monitoring in severe TBI patients (Alali et al, 2013). In a retrospective study performed
by Alali et al, it was found that the use of invasive ICP monitoring was associated with
lower in-hospital mortality rates for TBI patients, when compared to facilities that did not
use invasive ICP monitoring for severe TBI patients (Alali et al, 2013).
ICP monitoring is an invasive technique that is associated with risks such as
infection at the catheter placement site and hemorrhage or device malfunction. Therefore,
it is only employed when patients exhibit signs of significant risk, which is usually
evident on head CT scans. Detectable abnormalities include contusions, hematomas,
herniation, edema and compression of basal cisterns (Rangel-Castillo et al, 2009).
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Current methods for ICP monitoring include the use of catheters in epidural,
subdural, subarachnoid, parenchymal, and ventricular locations, with ventricular
catheterization being the most common. Ventricular catheterization is often the most
viable method as it is reliable, low-cost, and more accurate than other options. An added
benefit is that this same catheter can be used for CSF drainage in the event that ICP needs
to be lowered. ICP lowering techniques are employed when an ICP of 20 mmHg or above
is detected (Haddad et al, 2012).
Elevated ICP is treated clinically based on the symptoms exhibited at the present
time. Treatment is centered on protecting the airway, breathing, and circulation in an
effort to maintain sufficient cerebral perfusion and avoid ischemic events. This is
accomplished by administering oxygen, assuring adequate ventilation, and possibly
hyperventilation in cases of herniation in order to decrease carbon dioxide concentration
and induce vasoconstriction to lower ICP (Snyder, 2012).
1.3.2.1 Medical Interventions
A common method to alleviate elevated ICP is the use of non-invasive
hyperosmolar therapy (Rangel-Castillo et al, 2009). Osmotic diuretics such as mannitol
and hypertonic saline (Rangel-Castillo et al, 2009) may be administered in order to draw
excess fluid as a consequence of edema from the brain tissue and into intravascular space
for elimination. This method, however, may not be ideal for all patients, such as those
with previously existing conditions such as renal failure, hematomas or other bloodrelated etiologies (Snyder, 2012). It is more successful in lowering ICP in patients who
have an intact autoregulation system, as compared to those who do not. Specifically, with
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a functional autoregulation system, mannitol can induce cerebral vasoconstriction which
in turn maintains stable CBF and significantly lowers ICP. When the patient is unable to
autoregulate pressure, mannitol only increases CBF, which leads to a small decrease in
ICP (Rangel-Castillo et al, 2009).
Hypothermia (reducing body temperature to 32°C) is another treatment method
used to control elevated ICP and improve patient overall outcome. There are several
mechanisms through which this technique improves brain condition which include the
following: improving cerebral blood flow, reducing metabolic rate, calcium antagonism,
preventing excitotoxic cascades, preserving protein synthesis, modulating inflammatory
response, protecting white matter, modulating apoptosis, and decreasing edema formation
(Xiong et al, 2012). In a study performed by Markgraf et al, rats showed decreased
cerebral edema and improved functional outcomes when hypothermia had been
administered either immediately or 1 hour after TBI was sustained, as compared to those
who had received the same treatment after 90 or 120 minutes where no benefit was
observed (Markgraf et al, 2001). In a patient study, it was found that hypothermia
sustained for at least 48 hours showed the best outcome, however this also puts the
patient at risk of pneumonia. Hypothermia may also be beneficial to traumatic axonal
injury, which is commonly observed in severe TBI (Xiong et al, 2012).
A last resort for severe TBI treatment is the administration of barbiturates to induce
coma. This method should only be considered if the patient experiences refractory
intracranial hypertension (RICH, when intracranial pressure exceeds 25 mmHg for 30
minutes, 30 mmHg for 15 minutes, or 40 mmHg for 1 minute) because it is often
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associated with serious complications such as hypotension and immunosuppression
(Censullo et al, 2003; Haddad et al, 2012). This treatment method may be selected in
order to sedate the patient if their behavior becomes harmful to their condition, if it is
beneficial to immediately reduce the metabolic needs of the brain tissue (Snyder, 2012),
or to immediately lower ICP by lowering the metabolism, and in turn lowering CBF
(Haddad et al, 2012).
1.3.2.2 Surgical Interventions
The primary surgical procedure performed to alleviate elevated ICP is the removal
of mass lesions such as acute epidural and subdural hematomas. Secondly, CSF drainage
is employed by inserting a catheter into the ventricular space in order to immediately
lower intracranial fluid volume and ICP (Rangel-Castillo et al, 2009).
Another last resort treatment for severe TBI and intracranial hypertension is
decompressive craniectomy, in the event that medical management fails (Haddad et al,
2012). Surgeons remove a portion of the skull in order to allow the swelling brain tissue
to expand without being compressed against the rigid skull, and by opening the fixed
volume of the skull, ICP is reduced (Xiong et al, 2009). The favorability of this technique
is currently debated since conflicting evidence exists for its effect on patient outcome.
Current clinical trials aim to clarify issues associated with the technique in regard to the
timing of the operation, its role in secondary injury, and brain edema formation (Xiong et
al, 2009). This method is used only as a last-ditch effort when the patient is close to death
(Haddad et al, 2012).
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1.4

Neuronal Cell Responses to Stress
Brain cells regularly experience stresses and respond to them accordingly. Several

environmental stimuli such as drugs, cytokines, hydrostatic pressure, and other
mechanical forces can evoke stress responses in cells. One response commonly examined
in drug studies on neuronal cells is neurite retraction, since it is easily observable in this
cell type.
1.2.1 Neurite Retraction
Neurites are mainly composed of two cytoskeleton elements- microfilaments, and
microtubules. Microtubules consist of tubulin and microtubule-associated proteins
(MAPs), which when phosphorylated, appear to effect microtubule stability and
dynamics. Neurite extension and retraction is controlled by reorganization of these
components with the help of molecular motors, which are still not entirely understood
(Sayas et al, 2006).
1.2.1.1 Causes and Mechanisms
Neurite retraction has been studied in relation to several disease states. Neurite
retraction plays a significant role in the progression of neurodegenerative diseases, as
well as CNS injuries and glaucoma. Pathways have been identified as moderators of
neurite retraction and extension, however their specific stimuli haven’t been identified. It
is also unclear through which pathway hydrostatic pressure as a stimulus affects neuronal
cells.
The Rho/ ROCK pathway has been identified as a moderator of actin cytoskeleton
and consequentially neurite structure in previous studies (Hirose et al, 1988; Sun et al,
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2011; Monnier et al, 2003). Specifically, activation of the small GTPase Rho and its
downstream effector Rho kinase have been demonstrated to play a role in neurite
retraction via the disassembly of intermediate filaments and microtubules (Hirose et al,
1988). Additionally, a pyridine derivative Y-27632 has been characterized as a specific
inhibitor of p160ROCK, a Rho-associated coiled coil-forming protein kinase within the
Rho/ROCK pathway, which was shown to prevent neurite retraction in neuroblastoma
N1E-115 cells (Hirose et al, 1988; Monnier et al, 2003). In a study by Hirose et al, N1E115 cells were serum-starved to induce neurite extension, then exposed to Y-27632. An
agonist known to stimulate neurite retraction, lysophosphatidic acid (LPA), was added to
the cell culture. Results indicated that p160ROCK was a downstream effector responsible
for agonist-induced neurite retraction since the addition of Y-27632 prevented neurite
retraction (Hirose et al, 1988). In a study by Sayas, glycogen synthase kinase-3 (GSK-3)
was found to be activated by LPA in primary neurons based on GSK-3 activity
measurement, while GSK-3 inhibition partially blocked neurite retraction. Additionally,
results indicated that Neuro2A cells experience GSK-3 activation is mediated by the
small GTPase RhoA (Sayas, 2006).
1.2.1.2 Indications and Consequences
Neurites are an important component of the neuronal cell body as they establish
synapses with other neurons, and thus create the interconnected neuronal network present
in the brain. Neurite outgrowth during neurodevelopment is essential for neuronal
connectivity, and a lack thereof can lead to cognitive deficits (Radio et al, 2008). While
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several factors may have an influence on neurite retraction, the consequences involve loss
of connection and communication in the neuronal network, and thus limited function.
Neurite outgrowth is commonly used to assess neuroInveity of certain chemicals. A
reduction in length is interpreted as an interruption of proper development, and indicates
some level of neurotoxicity with the assumption that the chemical of concern induces
changes in molecular signaling pathways responsible for neurite extension (Radio et al,
2008).
Neurite retraction is also associated with neurodegenerative diseases.
Characteristics common to all neurodegenerative diseases include neurite retraction,
synapse disruption and destruction, and eventual cell death (Sheinerman et al, 2013).
Additionally, LPA-induced neurite retraction has been associated with Tau
phosphorylation, which is seen in the Alzheimer’s disease state. In a study by Sayas et al,
it was determined that Tau phosphorylation was modulated by GSK-3 in the Rho
pathway. It is possible that activation of GSK-3 involved in neurite retraction may also be
linked to Alzheimer’s disease (Sayas et al, 1999).
1.2.2 Neurite Retraction in TBI
Several indicators of neuronal injury exist, including blebbing, neurite retraction,
and neurite thinning (Bar-Kochba et al, 2016). Neuronal injury and neurite retraction
have been observed in experimental models of TBI that study the effects of mechanical
insult from the primary injury.
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1.2.2.1 In Vitro Findings
Neurite injury and retraction have been observed in studies using cell culture
models of TBI. A study performed by Bar-Kochba et al utilized a 3D compression model,
consisting of primary cortical neurons cultured in collagen type I gels, to characterize the
effects of compressive impacts with specific strain rates on neuronal morphology.
Samples were subjected to an compressive impact with different loading rates, at a
compressive strain of 0.38 in quasistatic and dynamic loading. Through the use of
confocal time-lapse microscopy, it was discovered that cytoskeleton showed signs of
structural degeneration- including neurite retraction, thinning, and blebbing- six hours
after experiencing the impact, then proceeding to deteriorate completely within four
hours, eventually leading to cell death (Bar-Kochba et al, 2016).
Using micropatterned neuronal cell culture silicone membranes, Tang-Schomer et
al modeled high strain rates responsible for white matter deformation in TBI. It was
determined that dynamic stretching of neurons induced mechanical failure in axonal
microtubules, which was responsible for disruption in axonal transport and swelling due
to protein accumulation, leading to the complete axonal degeneration and eventual death
of neurons (Tang-Schomer et al, 2010).
A study by Prado et al modeled TBI by using a novel device to apply stress to
primary cortical neuronal cultures on a microelectrode array. Results indicated that
membrane permeability was increased, along with spontaneous electrical activity
perturbations, suggestive of electrophysiological dysfunction in the interconnected
neuronal network (Prado et al, 2005).
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1.2.2.2 In Vivo Findings
Previous in vivo studies have elucidated the effects that TBI has on neuronal and
neurite morphology (Wu et al, 2012; Gao et al, 2011; DiLeanordi et al, 2009; Casella et
al, 2014).
Several histological results following controlled cortical impact (CCI) injury to
rodent models have illustrated the effects on tissue components. In a study by Wu et al,
after CCI to the left hemisphere of Wistar rat subjects, it was discovered that along with
neurological functional deficits, rats experienced axonal injury and decreased synaptic
density following the injury (Wu et al, 2012). In a separate study, dentate gyrus tissue
sections revealed that there was a significant decrease in dendritic length and dendritic
branching following CCI injury to juvenile rat subjects when compared to the non-injured
control (Casella et al, 2014). A mouse CCI injury model of mild TBI revealed that while
there were no significant tissue lesions or cortex volume changes, there was evidence of
some neuronal death and evidence of extensive dendritic degeneration marked by
swelling and blebbing. Additionally, the number of apical dendrites and dendrite
branches in pyramidal cells was greatly reduced in the mild TBI model, as well as the
number of synapses between cells, and consequentially disruption of the neural circuitry.
Since synapse degeneration was observed without the occurrence of neuronal death
following the injury, it is possible that degeneration and death are separate processes that
should be prevented individually (Gao et al, 2011).
A study that experimentally induced a diffuse injury TBI to a juvenile rat model
demonstrated that axon swelling can occur in the cingulum 6 hours post-injury, followed
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by additional axon swelling in the corpus callosum and lateral white matter tracts after 24
hours. At 72 hours post-injury, results indicated axonal degeneration (DiLeonardi et al,
2009).
Past studies have focused on the primary mechanical insult of TBI as the root cause
for axonal injury, yet fail to evaluate how elevated ICP may contribute to pathologic
mechanotransduction processes as well.
1.3 Effects of Hydrostatic Pressure on Neuronal Cells
The application of hydrostatic pressure on different cell types and tissues is
clinically relevant to a multitude of disease states. Hydrostatic pressure can mimic the
functions of pressure states found in the body such as hypertension, elevated ICP, and
intraocular pressure. By investigating the effect of hydrostatic pressure on a number of
cell types and tissues, it may prove helpful in understanding the underlying mechanisms
of cellular responses to TBI.
1.3.1 Associated Pathologies
There are several pathologies that result from or are exacerbated by super
physiological levels of pressure. As previously discussed, TBI patients experience
elevated ICP as a secondary condition, which has a direct effect on the physiology of the
brain, and may lead to additional consequences such as neurodegenerative diseases.
Another pathology that involves increased pressure is glaucoma. Glaucoma is
associated with elevated intraocular pressure and the progressive degeneration of optic
nerves, leading to loss of vision and eventually irreparable blindness. Retinal ganglion
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cell death is a major factor involved in the pathophysiology of the disease, and may be
wholly or in part due to increased intraocular pressure (IOP) (Almasieh et al, 2012).
1.5.2 Effect on Cells
Several in vitro studies have been performed to determine the effect of hydrostatic
pressure on specific cell types to gain understanding of its physiological role in disease
states. Cultured retinal ganglion cells (RGCs) are used in glaucoma model studies, as
well as PC12 cells, which are also used in neurodegenerative disease studies.
1.5.2.1 Retinal Ganglion Cells
RGCs are a type of Central Nervous System (CNS) neuron whose soma is located
in the retina, and whose axons are located in the optic nerve (Almasieh et al, 2012).
Studies have been performed on RGCs to determine if the elevated pressure contributes
to neuronal apoptosis. In a study using differentiated RGC-5 cells housed in a pressurized
live cell imaging chamber, it was discovered that after application of 100 mmHg pressure
(a pressure that resembles the intraocular pressure observed in acute angle-closure
glaucoma), the cells experienced peaks of intracellular Ca2+ elevation, followed by
caspase-3/7 activation. Intracellular Ca2+ is a known apoptosis regulator, and caspase-3/7
an apoptosis effector, so it was expected that the peaks of intracellular Ca2+ would
correspond with morphological changes in the cells associated with apoptosis- cell
shrinkage, and neurite retraction, which they did. This correlation of Ca2+ peaks with the
morphological changes indicates that Ca2+ is the initiator of apoptosis in RGCs (Lee et al,
2010).
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According to a 2013 study, results suggest that elevated IOP (90 mmHg for 1 hour)
in a rat model resulted in the upregulation of the P2X7 receptor, and was responsible for
RGC death. The P2X7 receptor is likely responsible for the upregulation of tumor
necrosis factor (TNF)-α, interleukin (IL)-1β (a mediator in chronic inflammation and
neurodegeneration), and IL-6 inflammation responses which contributed to cell death, as
well as intracellular Ca2+ increase (Sugiyama et al, 2013). As observed in the previous
study, elevated intracellular Ca2+ levels correlate to apoptosis. Other studies suggest
transient receptor potential vanilloid-1 (TRPV1) expression may play a role in the
increase of intracellular Ca2+ as well. TRPV1 is a channel that mediates multiple Ca2+
related cascades that influence the cell’s response to mechanical. In a glaucoma state
mouse model, elevated IOP correlated with increased levels of TRPV1 and apoptosis
(Sappington et al, 2015).
In addition to Ca2+ increase, apoptosis, and inflammatory response, new evidence
suggests that elevated IOP induces oxidative stress in RGCs, which leads to neuronal
damage. A study performed on both RGC-5 cells in culture and a mouse model
concluded that after application of either 30 or 100 mmHg hydrostatic pressure, the
oxidation products 4-hydroxy-2-nonenal (HNE) and heme oxygenase-1 (HO-1) were
elevated in a dose-dependent manner. Results showed that HNE is toxic to RGC-5 cells,
as it killed them in a dose-dependent manner. When pretreated with antioxidant
resveratrol, HNE adduct formation was reduced in RGC-5 cells (Liu et all, 2007).
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1.5.2.2 PC12 Cells
As an in vitro glaucoma model, PC12 cells (a rat adrenal phaeochromocytoma cell
line, Westerink et al, 2008) subjected to elevated hydrostatic pressure experienced
mitochondrial membrane depolarization that resulted in apoptosis and oxidative stress.
PC12 cells in culture were exposed to 0, 15, and 70 mmHg hydrostatic pressure for 1 and
24 hours. Afterwards, several factors were examined including cell viability, lipid
peroxidation and intracellular reactive oxygen species production, mitochondrial
membrane depolarization, reduced glutathione (GSH) and glutathione peroxidase (GSHPx), cell apoptosis, and caspase-3 and caspase-9 activities. When hydrostatic pressure
was applied at either 15 or 70 mmHg, PC12 cells experienced oxidative cell damage as
indicated by decreased GSH and GSH-Px values, as well as increased membrane
potential of PC12 mitochondria, suggesting compromised mitochondrial activity.
Application of 70 mmHg for 24 hours resulted in apoptosis as indicated by caspase-3 and
caspase-9 values (Tök et al, 2014).
Another study indicate that neuronal exposure to increased pressure (as a model of
high ICP in TBI patients) plays a role in the development of neurodegenerative disease.
Neurodegenerative diseases such as Parkinson’s and Amyotrophic Lateral Sclerosis
(ALS) develop as a result of protein aggregation comprised mainly of α-synuclein (AS).
PC12 cells in suspension were subjected to either 500 or 1000 bars (375,030 mmHg to
750,051 mmHg) of hydrostatic pressure for a certain period of time, and then allowed 24
hours to recover. Western Blot results indicated that acute increases in hydrostatic
pressure caused aggregation of intracellular endogenous AS, a decrease in its binding
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partner PLCβ1, and reduced binding between in the two in PC12 cells. However, the
exact mechanism through which this occurs remains unknown (Golebiewska et al, 2015).
Although pressures used in this specific study were far greater than ICP observed in TBI
patients, the results may be relevant. If PC12 cell behavior models central nervous system
neuronal behavior as predicted, it is possible that increased ICP stemming from TBI
contributes to the development of neurodegenerative diseases through the accumulation
of AS,.
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CHAPTER TWO
RESEARCH RATIONALE
2.1 Rationale
Approximately 1.7 million TBIs ranging from mild to severe occur every year in
the United States (MedGadget, 2016). Resulting elevated ICP is managed with treatments
such as hyperosmolar therapy, hypothermia, or craniectomy to reduce risk of ischemia
(Rangel-Castillo et al, 2009; Xiong et al, 2012). However, it remains unclear what role
elevated ICP has directly on cellular structure, and how it may play a role in pathological
mechanotransduction pathways. Axonal degeneration, neurite retraction, and increased
plasma membrane permeability are morphological characteristics that have been
observed in several TBI models in vitro and in vivo studies. Since neurite retraction is a
hallmark characteristic of neuronal cells in neurodegenerative diseases and functional
nervous system deficits, it is possible that neurite retraction induced by TBI may manifest
into the development of such pathologies. The present study investigates the direct role of
elevated hydrostatic pressure on neuronal morphology alteration to elucidate processes
that can be targeted for treatment options for TBI patients.
2.2 Hypotheses
The objective of this present research is to test our hypothesis that neuronal cells
respond to elevated hydrostatic pressure, and that this response is a facilitated via a
specific pathway. To test this hypothesis, using custom experimental setups, mouse
Neuro2A cells were subjected to controlled levels of hydrostatic pressure for specific
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time periods, and cell morphology and apoptosis activity were examined. The specific
aims for this project are as follows:
• Aim 1: To quantify changes in Neuro2A cell morphology following exposure to
elevated hydrostatic pressure
Rationale: Axons and dendrites are vital to forming connections in the
neural network that allow proper CNS function and cell-cell
communication. Neurite retraction may lead to limited communication and
therefore compromised functionality.
Approach: Neuronal cell morphology was compared before and after
exposure to hydrostatic pressure using fluorescent and phase contrast
microscopic images. Normalized change in neurite length per cell was
determined based on the comparison of “before” and “after” neurite
length summations.
• Aim 2: To determine whether elevated hydrostatic pressure induces apoptosis in
Neuro2A cells
Rationale: While direct injury to brain tissue during TBI can result in cell
death, it is unclear whether unrelieved elevated intracranial pressure as a
secondary injury associated with TBI contributes to cell death either
locally or globally in the brain.
Approach: A colorimetric TUNEL Assay, TiterTACS, was used to
determine whether Neuro2A cells underwent apoptosis after 1 hour or 24
hours of exposure to 35mmHg hydrostatic pressure.
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• Aim 3: To identify the mechanism through which hydrostatic pressure induces
neurite retraction in Neuro2A cells
Rationale: Once identified, the specific pathway could serve as a target for
therapeutics that would act to reduce or prevent neurite retraction in
neuronal cells induced by elevated intracranial pressure sustained after
TBI, and limit subsequent consequences.
Approach: Neuro2A cells were exposed to hydrostatic pressure in the
presence or absence of Y-27632, an inhibitor to p160ROCK in the
Rho/ROCK pathway. Neurite lengths for specific cells were measured and
compared to determine the role of Rho/ROCK pathway in pressureinduced neurite retraction.
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CHAPTER THREE
MATERIALS AND METHODS
3.1 Pressure System
In the present study a custom-made pressure system was used to expose neuronal
cell cultures to hydrostatic pressure. A computer with a custom LabView code (National
Instruments, Corporation, Austin, Texas) was used to regulate the pressure inside a sealed
pressure chamber, which housed the cell culture dishes. A pressure transducer was used
to monitor the pressure inside the pressure chamber and convey the pressure to LabView
using voltage output values. Based on the readings, inlet and outlet valves that controlled
the flow of 95% air/ 5% CO2 through the pressure system were adjusted. The pressure
chamber was housed inside an incubator under standard cell culture conditions.
In addition to the previous design of a rectangular chamber (Figure 1), a new
pressure chamber (Figure 2) was designed and fabricated in the present study to 1) limit
space inside the container for air to fill and therefore reducing pressure pump usage, 2)
provide a cylindrical shape to house petri dishes or cell culture dishes, 3) to achieve
capacity for higher pressures.
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Figure 1. Pressure Chamber 1. Rectangular pressure chamber with box lid
mechanism used for low-pressure experiments.

Figure 2. Pressure Chamber 2. Newly fabricated cylindrical pressure chamber
with screw-top lid for high-pressure experiments.
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3.2 Cell Culture
Neuro2A cells (ATCC), a mouse neuroblastoma cell line, were cultured in
Dulbecco’s Modified Eagle Medium (D-MEM) supplemented with 10% fetal bovine
serum (FBS) and 1% Penicillin-Streptomycin (Thermo Fisher Scientific) under standard
cell culture conditions with a humidified atmosphere of 95% air and 5% CO2 at 37°C.
Media were changed out every 48-72 hours. Cells were passaged when 80% confluency
was achieved, approximately once a week using a trypsin-EDTA solution (Corning).
In order to induce neurite extension, cells were serum-starved for 24 hours
(Figure 4). This was accomplished by replacing regular growth media (D-MEM, 10%
FBS, 1% Penicillin-Streptomycin) with serum-free media (100% D-MEM).
3.3 Soft Substrate Coating
To simulate an environment that mimicked that of brain tissue, a polyacrylamide
+ type I collagen layered substrate was prepared for Neuro2A cell culture. The protocol
in the present study was adapted from that developed by Fischer et al (Fischer et al,
2012).
3.3.1 Coverslip Acid Washing
One-inch circular glass coverslips (Fisher Scientific) were soaked in a beaker
containing 20ml 1M HCl in a hot water bath at 50-60°C under a fume hood for 8 hours
with occasional agitation. The coverslips were removed and rinsed extensively in distilled
water and subsequently in 100% ethanol. Coverslips were left to air-dry overnight.
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3.3.2 Coverslip Activation
The acid-washed coverslips were carefully placed in a wire rack and soaked in
0.5% (3-aminopropyl)trimethoxysilane (Sigma-Aldrich) in dH2O for 30 minutes at room
temperature with gentle agitation of the rack in solution. After washing in six changes of
dH2O the rack carrying the coverslips was dried on a hot plate and cooled to room
temperature. After cooling the coverslips on the rack were immersed in a 0.5%
glutaraldehyde (Polysciences)-PBS solution for 30 minutes at room temperature with
occasional agitation to prevent bubble accumulation on the coverslip surface. The
coverslips were then washed with three changes of distilled H2O and allowed to air-dry
overnight.
3.3.3 Polyacrylamide Gel Coating
Glass slides (Fisher Scientific) were polished with a KimWipe soaked in a
hydrophobic silicone solution (Rain-X, ITW Global Brands), rinsed well with distilled
water, and then allowed to air dry. Two glass slides were placed in each 15cm glass Petri
dishes. To prepare acrylamide gel with a shear modulus of 0.43 kPa to mimic that of
brain tissue (~0.49 kPa, Rashid et al, 2013), 0.2925 mL acrylamide, 0.1604 mL bisacrylamide, 2.0471 mL1M HEPES were mixed together for a total volume of 2.5 mL
with the final concentrations of 5% acrylamide and 0.05% bis-acrylamide. To this
mixture, 10 µL of TEMED and 15 µL of freshly made 10 % APS were added and mixed
briefly. Two 12 µL drops of the whole mixture were placed with 1 inch space apart on
each glass slide and one coverslip was carefully placed on each drop, with a small portion
of the coverslip overhanging the edge of the glass slide. The acrylamide mixture was
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allowed to polymerize at room temperature for 20 minutes. After polymerization was
completed, the surface of the slides and coverslips were flooded with freshly made 50
mM HEPES buffer. The coverslips were then removed from the glass slides using forceps
by applying lateral pressure to the overhanging edges of the coverslips. The coverslips
were placed gel side-up in another Petri dish and rinsed five times with 50 mM HEPES
buffer. The polyacrylamide-coated coverslips were stored in fresh 50 mM HEPES buffer
at 4°C overnight prior to the collagen coating step.
3.3.4 Type I Collagen Coating of Soft Substrates
Sulfo-SANPAH (Thermo Fisher Scientific) stock in dimethyl sulfoxide (DMSO,
ATCC) at a concentration of 25 mg/mL was prepared and flash-frozen in liquid nitrogen
for storage at -80°C. Four 40 µL aliquots of sulfo-SANPAH were thawed at room
temperature and 960 µL of distilled water was mixed with each aliquot. The type I
collagen solution was prepared at a concentration of 200 ug/mL in PBS. The cover slips
were placed gel side-up on a Parafilm coated Petri dish. 200 µL sulfo-SANPAH solution
was pipetted onto the polyacrylamide surface of each coverslip. The Petri dish supporting
the coverslips was placed on top of a heightened support in the cell culture hood so that it
was ~10 cm from the UV lamp and left for 10 minutes to induce cross-linking. After
excess buffer was removed from coverslips, each coverslip was inverted onto a single
collagen droplet so that the polyacrylamide surface was in contact with the droplet. The
collagen was allowed to covalently couple with the polyacrylamide overnight at 4°C. The
following day, the coverslips were rinsed with sterile PBS in sterile conditions and a grid
was drawn on the bottom of each coverslip with a permanent marker. Coverslips were
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stored in fresh sterile PBS in cell culture dishes. Coverslips were sterilized by UV light
for 3 hours at room temperature. Coverslips remained in their cell culture dishes and were
stored at 4°C.
3.3.5 Coomassie Blue Staining
To confirm the immobilization of collagen onto the soft substrates, the coverslips
were fixed in fixing solution (50% methanol, 10% glacial acetic acid in dH2O) for 3
hours and stained with Coomassie blue (40% methanol, 60% Coomassie Blue + acetic
acid in dH2O) for 20 minutes with gentle agitation. The samples were then destained
eight times in destaining solution (40% methanol, 10% glacial acetic acid in dH2O) and
stored for imaging in storage solution (5% glacial acetic acid in dH2O) Macroscopic
images were taken of each coverslip using a cell phone camera and microscopic images
were taken using phase contrast microscopy (10x, Nikon).
3.3.6 Cell Seeding onto Gel Coverslips
Each coverslip was rinsed in warm sterile PBS, then placed gel side up in a 35 mm
cell culture dish with 1 mL warm growth media. N2A cells (56,600 cells per dish) in
growth media were seeded on each coverslip and cultured for 24 hours.
3.4 Pressure Experiments
Prior to cell seeding, a grid coordinate system was drawn on the bottom of each cell
culture dish using a permanent marker (see Figure 3), which allowed for the relocation of
individual cells. Neuro2A cells were cultured in 35mm cell culture dishes at an initial
seeding density of 56,600 cells per dish in growth media for 24 hours. Growth media was
removed and cells were cultured in serum-free media (100% D-MEM) for 24 hours in
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order to induce neurite extension. At this point, “Before” images were taken of Neuro2A
cells using the microscope (Nikon). The specific cell locations were recorded in order to
locate the same cells for the “After” images. Using the custom setup (Section 3.1), the
cells were exposed to hydrostatic pressure (either 25 or 35 mmHg) for 30 min, 1hour, 2
hours, or 4 hours. Control was the cells that were prepared in a similar manner but
maintained under atmospheric pressure conditions for the duration of the experiments.
Immediately following the pressure application, cells in all dishes were fixed with 10%
neutral buffered formalin (NBF, Protocol) for 10 minutes.. “After” images of the same
cells captured in the “Before” images were taken using phase contrast microscopy
(Nikon).

Figure 3. Cell Culture Dish Grid Schematic. A coordinate grid that was
drawn on the bottom of each cell culture dish using a permanent marker was
used to locate cells.
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3.5 Microscopy
Cells were imaged using phase contrast and fluorescence microscopy (Nikon).
CellLight Actin-GFP, BacMam 2.0 (Thermo Fisher Scientific) was used to label actin in
the Neuro-2A cells with green fluorescent protein for live cell fluorescence imaging.
3.6 Neurite length analysis
3.6.1 Image analysis
Neurite length was measured for individual Neuro2A cells using the Fiji program
with the Simple Neurite Tracer plugin (Longair, 2011). The program allows for manual
selection of end points for measurement, and reports the length in units of pixels. The
number of neurites per cell, as well as the length of each neurite per cell were measured
on the “Before” images and the “After” images for all groups.
3.6.2 Calculations
Normalized change in neurite length was calculated using the following equation:

Equation 1. Equation used to determine average normalized change in
length per neurite per cell
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The variables are defined below:
ΔL = normalized change in neurite length per cell
l0 = combined length of neurites for a cell BEFORE
N0 = number of neurites for a cell BEFORE
l = combined length of neurites for a cell AFTER
Hence, ΔL=1 signifies no change in neurite length per cell, while a value above 1
indicates increase in neurite length, and a value below 1 represents a decrease in neurite
length.
3.7 p160 ROCK Inhibition
3.7.1 Part One: Pressure and Y-27632
To determine the potential mechanism for pressure-induced neurite retraction in
N2A cells, the pressure experiments (35 mmHg, 1 hour) were repeated with or without 30
min pre-treatment of cells with a ROCK inhibitor Y-27632 (1 µM, ATCC). Four
experimental groups were designated as 1- No Pressure, 2- No Pressure + Y-27632, 3Pressure, and 4- Pressure + Y-27632.
3.7.2 Part Two: LPA and Y-28632
In addition, to confirm the involvement of Rho-Rock pathway in neurite retraction
and effect of the inhibitor, a positive control experiment was performed.
Lysophosphatidic acid (LPA) is a bioactive phospholipid known to cause neurite
retraction in neuronal cells. By using it as a neurite retraction stimulus in place of
hydrostatic pressure, LPA was applied to cells in order to provide a comparison for the
reaction observed in cells exposed to pressure. Briefly, following serum-starvation for 24

37

hours, Neuro2A cells were treated with 1 µL Y-27632 solution each for 30 minutes and
imaged using phase contrast microscopy (Nikon). The cells were then treated with a
lysophosphatidic acid (LPA) solution [0.3mM LPA, Sigma-Aldrich, in PBS, Corning,
0.1% weight/ volume bovine serum albumin (BSA), Sigma-Alrich] for 10 minutes. Cells
in all dishes were fixed with 10% neutral buffered formalin (NBF, Protocol) for 7
minutes and imaged again.
3.8 TUNEL Assay
After pressure experiments (35 mmHg, for 1 hour or 24 hours), TUNEL assay
was performed using a commercially available kit (TiterTACSTM, Trevigen) and
following the manufacturer's instructions (Batch Method) to quantify apoptotic cells.
Duplicates for each group (4 groups total) were assayed. The 4 groups included the
following: Control group (no pressure), Pressure group, Positive control (nucleasetreated), and Negative control (unlabeled). The Control group, Positive control, and
Negative control groups all used cells that were not exposed to pressure.
3.9 Polyacrylamide / Collagen Type I Coating of Substrates
Soft culture substrates for N2A cells were prepared according to a published
method (REF), which is summarized in the following subsections.
3.10 Statistical Analysis
A paired t test (two tail) was performed when appropriate. The level of
significance used was p < 0.05. All data are presented as means ± standard errors of
mean.
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CHAPTER FOUR
RESULTS
4.1 Neuro2A Cell Neurite Extension
Neuro2A cells were cultured in growth medium containing D-MEM, 10% FBS,
1% Penicillin-Streptomycin for 24 hours. Medium was switched to serum-free media
(100% D-MEM) for 24 hours in order to induce neurite extension from the cell body.
Phase contrast images exhibited that there were more neurites per cell, and that those that
existed were longer in length in the serum-free media group (Figure 4A) than the regular
media group (Figure 4B).

Figure 4. Phase Contrast Images of Neuro2A Cells in Growth Medium and SerumFree Medium. Neuro2A cells cultured in regular growth media containing D-MEM,
10% FBS, 1% Penicillin-Streptomycin after 24 hours (A) and Neuro2A cells cultured in
serum-free growth media containing 100% D-MEM after 24 hours. Scale bars = 100 µm.
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4.2 Neurite Response to Pressure Exposure
4.2.1 Hard Substrate
To determine elevated hydrostatic pressure on neuronal cell morphology in vitro,
Neuro2A cells cultured in 35 mm plastic dishes (Greiner Bio-One) were exposure to
pressure (25 or 35 mmHg for up to 60 min) and imaged using phase contrast microscopy

(Nikon) (Figure5).
Figure 5. Phase Contrast Images of Neuro2A Cells Before and After Pressure
Application. Neuro2A cells cultured in serum-free media and imaged (A, D) at
time=0, (B) after 15 minutes in incubator (no pressure), (C) after 30 minutes in
incubator (no pressure), (E) after 15 minutes of exposure to 35 mmHg pressure, (F)
after 30 minutes of exposure to 35 mmHg pressure. Scale bars = 100 µm.
Neurite length of about 30 cells from each dish was measured and
normalized length was calculated for both the pressure group and a control group (no
pressure). The cells exposed to these two different pressures show similar general trend
and exhibited a decrease in neurite length when compared with the control. However,
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only application of 35 mmHg induced a significant (p<0.05) decrease in neurite length.
Based on these results, 35 mmHg pressure was used in subsequent experiments to
evaluate the effect of pressure on neurite length at additional time points.

Figure 6. Average Normalized Change in Neurite Length Over 1 Hour. Average
neurite length per cell was normalized over two 30-minute segments for control group
(no pressure) and pressure (either 25 mmHg or 35 mmHg) groups of Neuro2A cells.
Error bars indicate ± S.E.M. * indicates p < 0.05.
Overall, the results demonstrated that pressure group experiences a decrease in
neurite length when compared to the control group. Specifically, neurite length of the
Neuro2a cells decreased significantly (p<0.05) after 30 minutes, 60 minutes, and 4 hours
of exposure to 35 mmHg hydrostatic pressure. Additionally, it appears that change in
neurite length is time dependent up to at least 4 hours.

41

Figure 7. Average Normalized Change in Neurite Length Over Time at 35 mmHg
Pressure. Average neurite length per cell was normalized over time segments for control
group (no pressure) and pressure (35 mmHg) group of Neuro2A cells. Error bars indicate
± S.E.M. * indicates p < 0.05.
4.2.2 Soft Substrate
To examine neuronal cell morphology changes due to hydrostatic pressure in an
environment similar to that of brain tissue, a soft substrate was prepared based on the
published methods (Fischer et al, 2012). Cells seeded on the soft polyacrylamide gel +
type I collagen substrate were imaged using phase contrast microscopy (Nikon) before
and after exposure to either 35 mmHg pressure or no pressure (control) for 1 hour. Data
were compared to that acquired from the hard substrate experiment.
First, to confirm that the collagen was immobilized onto the polyacrylamide gel
layer on the coverslip, a Coomassie Blue stain was performed (de Moreno et al, 1986;
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Duhamel, 1983). Resulting images show that both coverslips A and B have clear and
blue-colored regions, with coverslip B having slightly more blue spots (Figure8).

A

B

Figure 8. Coomassie Blue Staining of Polyacrylamide Gel Coverslips. After
Coomassie Blue stain was performed, images were taken on a phone camera of the
coverslips which had either A) a polyacrylamide gel layer or B) a polyacrylamide gel
layer + type I collagen layer.
Unlike Neuro2A cells on the hard substrate, most Neuro2A cells on the soft
substrate appear to have a more rounded cell body and to have fewer neurite extensions
(Figure 9). Neuro2A cells seeded on the soft substrate appear to experience neurite
retraction similar to that of Neuro2A cells plated on the hard substrate when exposed to
35 mmHg hydrostatic pressure for 1 hour (Figure 10). Neurite length decreased
significantly on both the hard substrate and the soft substrate (p < 0.05).
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Figure 9. Phase Contrast Images of Neuro2A Cells Seeded on Soft Substrate.
Phase contrast images were taken of Neuro2A cells (A, C) at time=0, (B) after 1
hour (no pressure), and (D) after 1 hour of exposure to 35 mmHg hydrostatic
pressure. Scale bars = 100 µm.
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*

*

Figure 10. Average Normalized Change in Neurite Length Over 1 Hour on Hard
and Soft Substrates. Average neurite length per cell was normalized over 1 hour for
control group (no pressure) and pressure (35 mmHg) group of Neuro2A cells. Error
bars indicate ± S.E.M. * indicates p < 0.05.

4.3 p160 ROCK Inhibition
To determine whether hydrostatic pressure induced neurite retraction through the
Rho/ROCK pathway, experiments were repeated in the presence or absence of the p160
ROCK inhibitor Y-27632 with LPA-treated group of Neuro2A cells as a positive
control. Imaging of the cells and calculation of the normalized neurite
lengths demonstrated that the control groups and the Y-27632 groups experienced slight
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changes, while the others experienced a significant (p<0.05) decrease in length (Figure
11). There was a significant difference between the Y-27632-treated cells and non-treated
cells in both the pressure and LPA groups.

*

*

Figure 11. Average Normalized Change in Neurite Length Over 1 Hour for
Treatment Groups With or Without Exposure to Inhibitor Y-27632. Average
change in neurite length per cell was normalized over 1 hour for control group (no
pressure), control group (no pressure) + Y-27632, pressure (35 mmHg) group,
pressure (35 mmHg) group + Y-27632, LPA group, and LPA + Y-27632 group of
Neuro2A cells. Error bars indicate ± S.E.M. * indicates p < 0.05.
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4.4 Apoptosis Study
To determine the effect of elevated hydrostatic pressure on Neuro2A cell apoptosis, a
commercially available colorimetric TUNEL assay kit (Trevigen), was used to quantify
the level of apoptotic Neuro2A cells directly after 24 hours of exposure to pressure (35
mmHg). Positive (nuclease-treated group) and negative (unlabeled group) controls were
generated to interpret absorbance values, with high values (0.611-1.159) indicating 100%
apoptotic cells, and low values (~0.111-0.211) indicating minimal apoptotic cells present
(Figure 12). The average values indicate that minimal apoptosis is detected in both the
control and pressure groups with absorbance values of 0.3055 and 0.3500, respectively,
which fall between the positive and negative control absorbance values.
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Figure 12. Quantification of Apoptosis in Neuro2A Cells Using HT TiterTACS
Assay. TiterTACs Assay was performed to quantify apoptosis in Neuro2A cell
cultures directly after 24 hours of exposure to 35 mmHg hydrostatic pressure. Error
bars indicate ± S.E.M.
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CHAPTER FIVE
DISCUSSION
Although numerous studies have previously investigated pathological
mechanisms involved in TBI (Bar-Kochba et al, 2016; Casella et al, 2014; DiLeonardi et
al, 2009; Gao et al, 2011; Prado et al, 2005; Tang-Schomer et al, 2010; Wu et al,
2012; Xiong et al, 2009), none have studied the direct effect of elevated ICP on neuronal
cell mechanobiology. As there is currently no therapeutic treatment available for
secondary injury after TBI (which may be partly due to elevated ICP), researchers aim to
elucidate potential pathways to target for therapeutic approaches (Xiong et al, 2009).
Additionally, an understanding of the mechanisms involved in elevated ICP may provide
insight necessary to establish conventional elevated ICP management procedures in TBI
patients, which currently remains debated amongst physicians (Alali et al, 2013).
Previous studies have examined changes in neuronal cell morphology and health in vitro,
particularly neurite extension/retraction and apoptosis, in order to evaluate cell health in
response to drugs and other chemicals (Hirose et al, 1988; Monnier et al, 2003; Sayas,
2006). In the present study, changes in neurite length was measured to determine the
effect of elevated hydrostatic pressure on Neuro2A cells as an in vitro model of TBIassociated elevated ICP. It was hypothesized that elevated hydrostatic pressure would
induce neurite retraction, and possibly apoptosis, in the Neuro2A cell culture model.
5.1 Neuro2A Cell Differentiation
Neuroblastoma cells are frequently used in in vitro studies to investigate neuronal
cell behavior (Seeds et al, 1970; Schubert et al, 1974). A number of methods exist for
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differentiating neuroblastoma cell lines and inducing neurite outgrowth, with the simplest
being exposure to serum-free medium (Gurwitz et al, 1988; Schubert et al, 1971;
Schubert et al, 1974; Seeds et al, 1970). When serum is removed from the environment,
the protein synthesis that is required for the microtubule assembly involved in
neurite extension, occurs (Seeds et al, 1970). Additionally, it is possible that after serum
removal, the cells are able to interact with the plate surface more stably, and thus
form neurites on its surface (Seeds et al, 1970; Schubert et al, 1971). In the present study,
Neuro2A cells were first cultured in growth medium (D-MEM, 10% FBS, 1% PenicillinStreptomycin), then switched to serum-free medium (100% D-MEM) after 24 hours,
which led to successful differentiation indicated by neurite outgrowth. In the present
study, differentiation was necessary in order to achieve a neuronal phenotype as clinically
relevant as possible.
5.2 Neurite Response to Pressure Exposure
The present study examined the effects of elevated hydrostatic pressure on
Neuro2A cell morphology, particularly neurite retraction/extension. The majority of
the experiments were performed in polystyrene cell culture dishes (Greiner Bioone) while some experiments were performed with a soft substrate layer (Greiner Bioone, plus polyacrylamide + type I collagen gel) to mimic brain tissue stiffness.
5.2.1 Hard Substrate
Differentiated Neuro2A cells were exposed to pressure (25 mmHg or 35 mmHg) for
either 15 minutes, 30 minutes, 60 minutes, 4 hours, or 6 hours. The pressures of 25
mmHg and 35 mmHg were selected to mimic those of ICP observed in moderate and
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severe TBI patients, respectively (Rangel-Castillo et al, 2008). Phase contrast
images analyzed with the Fiji program with the Simple Neurite Tracer plugin (Longair,
2011) showed that there was neurite retraction and extension in both the control and
pressure groups. This is most likely due to the fact that the cells naturally migrate, as well
as react to differences in temperature when being removed from the incubator and being
transported to the microscope. Thus, the study aimed to compare the amounts of change
in neurite length between the control and pressure groups in order to determine whether
there was a difference.
The results comparing the 25 mmHg and 35 mmHg pressure groups provided
evidence that cells in the 35 mmHg group experienced a more drastic decrease in neurite
length than those in the 25 mmHg group when exposed to pressure for 30 and 60 minutes
(Figure 6). The trend indicated that neurite retraction may occur at moderate pressures
(~25 mmHg), and progress extensively as pressure continues to rise (to at least 35
mmHg).
Since Neuro2A cell exposure to 35 mmHg pressure results indicated that there was
significant impact, subsequent studies were performed in order to more closely examine
the effect of 35 mmHg pressure on neuronal cell morphology at additional time
points. The results provide evidence that exposure to 35 mmHg pressure for 30 minutes
or more causes significant (p<0.05) neurite retraction in Neuro2A cells in cell culture
dishes. After 6 hours of exposure to 35 mmHg pressure, neurite length did not decrease
as much as it did after 4 hours. While it is possible that neurites began extending after the
4 hour time point, the observation in the 6 hour group is most likely due to the fact that
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there was greater variability in the data due to more extensive cell migration after such a
long period of time.
Together, the results indicate that neuronal cells present in brain tissue exposed to
elevated ICP in severe TBI patients may experience neurite retraction. Neurite retraction
induced by ICP may lead to disruption in the brain's neuronal network by destroying
synapses and cell-to-cell communication (Gao et al, 2011). It is possible that neurite
retraction as a result of elevated hydrostatic pressure may play a role in the development
of long-term consequences commonly observed in TBI patients such as
neurodegenerative diseases (Chen et al, 2007; Fleminger et al, 2003; Jafari et al, 2013;
Mortimer et al, 1991) and cognitive deficits (Caeyenburghs et al, 2014) since these are
also characterized by neurite retraction (Radio et al, 2008; Sheinerman et al,
2013). Additionally, the presented evidence supports the notion that elevated ICP (~35
mmHg) in severe TBI patients should be relieved as soon as possible, ideally within 30
minutes of elevated ICP detection, in order to avoid neuronal cell damage. Neurite
retraction is one form of neuronal cell damage that was observed, however,
additional cellular pathologic events may occur that were not observed in the present
study.
5.2.2 Soft Substrate
Previous studies have thoroughly documented changes in cell morphology and stem
differentiation based on substrate stiffness (Engler et al, 2006; Yeung et al, 2005). The
brain is a soft organ, with brain tissue having a shear modulus of about 0.49 kPa
(Rashid et al, 2013), which is much lower than that of a rigid plastic cell culture dish
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(~ 1 GPa) (Sayed et al, 2015), thus cells may have behaved differently based on the
substrate used.
To confirm the validity of the results from initial experiments using hard
polystyrene cell culture dishes, experiments were repeated using a soft
substrate that consisted of a coverslip with a polyacrylamide gel layer coated with a type
I collagen layer. First, to confirm the presence of collagen on the polyacrylamide gel
layer, the specimens were stained with Coomassie Blue. The results indicated that some
protein may be present on both the polyacrylamide gel coverslip and the polyacrylamide
gel + type I collagen coverslip. This may have been due to unsuccessful destaining
procedure, or actual presence of type I collagen or some other protein on both coverslips.
Despite Coomassie Blue stain results, cells were seeded on the polyacrylamide gel + type
I collagen coverslips. After 24 hours, it was evident that the Neuro2A cells seeded
on the polyacrylamide gel + type I collagen coverslips had adhered. Since type I collagen
was necessary for cell adherence to the substrate, the results indicate that the type I
collagen immobilization was successful. Images showed that Neuro2A cells plated on the
soft substrate exhibited little neurite outgrowth following serum-free culture, especially
when compared to that of Neuro2A cells in cell culture dishes (Figure 9). However, some
cells with neurite extension were identified and the results demonstrate that
Neuro2A neurites retract significantly after 1 hour of exposure to 35 mmHg pressure on
the soft substrate. This finding supports the view that the hard substrate experiments
serve as valid models for studying elevated ICP on neuronal cell morphology in vitro.
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5.3 p160 ROCK Inhibition
Previous studies have shown that the Rho/ROCK pathway is responsible for neurite
retraction induced by external stimuli such as LPA (Hirose et al, 1988; Monnier et al,
2003). However, none have yet examined how hydrostatic pressure specifically induces
neurite retraction. When the p160ROCK inhibitor Y-27632 was administered to neuronal
cell cultures prior to pressure exposure (35 mmHg for 1 hour), there was
significantly (p<0.05) less neurite retraction when compared to the cultures that were
exposed to pressure without prior administration of Y-27632, suggesting that Y-27632
blocked the effects of Additionally, when LPA was administered to Neuro2A cells in the
present study neurite retraction occurred as expected. However, when cells were treated
with Y-27632 prior to LPA, the effect of LPA was blocked. These results indicate that
hydrostatic pressure is transduced to induce neurite retraction through the same pathway
that LPA is and that the pathway responsible is the Rho/ROCK pathway.
5.4 Apoptosis Study
Numerous studies have demonstrated that neuronal cell death occurs as a result of
TBI (Pekna et al, 2012; Xiong et al, 2009). Specific causes such as ischemia to brain
tissue, diffuse axonal injury, and direct trauma to neuronal cells have been
identified as contributors (Gaetz, 2004; Werner et al, 2007). The present study
investigated whether elevated hydrostatic pressure contributed to the neuronal cell
death and a commercially available TUNEL assay kit (Trevigen) was used to quantify
apoptotic cells in a control group and groups exposed to pressure. Results demonstrate
that following 24 hours of exposure to 35 mmHg pressure, similar and minimal Neuro2A
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cell apoptosis occurred for the control and pressure groups. While the values of the
nuclease-treated group were similar to the other groups, it was due to the large variance
and, the nuclease-treated absorbance values in two out of three trials were higher (~1.15)
than those represented in Figure 12. Although these in vitro results suggest that elevated
hydrostatic pressure alone is likely not responsible for neuronal cell death, it remains
possible that in the presence of other cell types in the in vivo environment, other
mechanisms may be involved that would lead to neuronal cell apoptosis due to elevated
ICP.
5.5 Limitations
As previously discussed, the present study used an in vitro system to model TBIassociated elevated ICP. While hydrostatic pressure could be closely monitored and
controlled, the scope of the study was limited in regard to several factors.
In the present study, pressure experiments relied on the measurement of
extensions from Neuro2A cell bodies, collectively called “neurites”. Neurites include
both axons and dendrites, however the two were not distinguished from each other for
simplicity of data collection and analysis in the study.
Throughout the study, Neuro2A cells were cultured in an incubator with a
humidified atmosphere of 95% air and 5% CO2 at 37°C. This models hyperventilation,
which is not representative of physiological conditions experienced in healthy brain
tissue. Normally, neurons present in brain conrtex are exposed to low oxygen levels
(Ndubuizu et al, 2007). Therefore, oxygen concentration would need to be adjusted to
more accurately model physiological conditions in future studies.
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In the pressure experiments, Neuro2A cells were first cultured in growth medium,
then switched to serum-free medium after 24 hour to induce neurite extension. Pressure
experiments were carried out while cells were in serum-free medium, however cells in
brain tissue exposed to elevated ICP would have access to additional nutrients in the
environment. For a more accurate TBI model, cells should be cultured with complete
nutrients available in brain tissue, as cells may behave differently.
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CHAPTER SIX
CONCLUSIONS AND RECCOMENDATIONS
In the present study, exposure to elevated hydrostatic pressure (35 mHg) for at
least 30 minutes was proven to induce neurite retraction in Neuro2A cells in vitro.
However, 24-hour exposure to elevated hydrostatic pressure did not induce neuronal
apoptosis. Additionally, the study provides evidence that the pressure-induced neurite
retraction response is mediated by the Rho/ROCK pathway. The presented findings may
be applied to future TBI pathology studies in order to elucidate potential solutions to
treating elevated ICP. Future studies include the following:
•

To clarify the effect of hydrostatic pressure on neuronal apoptosis by

performing additional experiments that expose Neuro2A cells to 35 mmHg
hydrostatic pressure for 24 hours and 48 hours.
o

Rationale: Current results suggest that minimal apoptosis occurs

after 24 hours of exposure to 35 mmHg hydrostatic pressure, however
the positive control values remained low. Additional trials of the
experiment should be run. Further, longer exposure to hydrostatic
pressure may elucidate apoptotic events later on.

•

To identify and examine the components present in the neurite structures

using stains for actin and microtubules before and after pressure exposure in
Neuro2A cells.
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o

Rationale: Specification of molecular components and their

activity may provide information regarding Rho/ROCK pathway
mechanisms involved in pressure-induced neurite retraction.
•

To establish in vitro synapse formation by using a stem cell-derived

neuron platform such as induced pluripotent stem cells (Bradford et al, 2015)
in order to evaluate the effect of hydrostatic pressure on synapses.
o

Rationale: Current results suggest hydrostatic pressure induces

neurite retraction which may indicate loss in synapses. However, there
is no evidence that synapse destruction does occur.
•

To investigate the effects of hydrostatic pressure on an animal brain tissue

sample.
o

Rationale: Since all physiological structures and cell types are

included in the brain tissue sample, it would provide a highly accurate
model for TBI-related ICP studies.
•

To combine the application of hydrostatic pressure with another model of

TBI pathology in order to produce a more relevant TBI disease model.
o

Rationale: In order to achieve the most accurate model, all

environmental factors should be included. Other studies without ICP
elevation considerations may not produce accurate results. Elevated
ICP may exacerbate pathological conditions or influence cells.
•

To investigate the effects of hydrostatic pressure application on a co-

culture composed of multiple cell types naturally present in brain tissue
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including primary neurons, astrocytes, oligodendrocytes, and microglia from a
rat.
o

Rationale: Primary neurons are a better representation of cells in

the brain than Neuro2A cells, and would therefore serve as better
predictors for neuronal behavior to elevated hydrostatic pressure
experienced during brain swelling following TBI. While neurons may
be the primary functioning cell type in brain tissue, it is important to
evaluate the response of the surrounding support cells as well.
Elevated hydrostatic pressure may have an effect on these cell types
independently, or may induce them to impact neurons in an indirect
way.
•

To investigate the effects of hydrostatic pressure application on a brain

tissue- like construct seeded with multiple cell types naturally present in brain
tissue including primary neurons, astrocytes, oligodendrocytes, and
microglia.
o

Rationale: Cells may respond in a different manner when exposed

to hydrostatic pressure while on a compliant soft tissue model as
compared to soft substrates in plastic dishes.
•

To conduct an animal study in which two mice receive blunt TBIs,

followed by the administration of Y-27632 in one mouse, and no treatment in
the other. Following the injury and recovery time, mouse behavior would be
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evaluated. Extraction and analysis of brain tissue morphology would be
examined post-humously.
o

Rationale: A mouse model would provide evidence as to whether

the inhibitor has an effect on the mouse behavior or brain tissue
morphology as compared to the control.
•

To examine cell morphology in brain tissue samples after rat brain is

exposed to elevated hydrostatic pressure, and compare these to brain tissue
samples of healthy rat brain.
o

Rationale: When investigating cell behavior and response to

stimuli, actual tissue samples provide more accurate evidence than do
cell culture models.
•

To determine through which specific receptor hydrostatic pressure

stimulates neurite retraction in neuronal cells.
o

Rationale: Another potential target for drug therapy may be the

specific receptor involved in pressure-mediated responses.
•

To develop a live imaging pressure chamber system to record videos or

take time-lapse images of cells in real time.
o

Rationale: This would allow investigators to observe neuronal

morphological change in real-time and better assess cell behavior, as
well as provide clearer evidence to support the conclusion that 35
mmHg pressure causes neurite retraction in Neuro-2A cells.
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